Nisha Singh Selected Research

ebselen

12/2020	A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.
9/2020	Effects of the putative lithium mimetic ebselen on pilocarpine-induced neural activity.
7/2016	Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing.
3/2016	Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla.
1/2016	Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.
1/2013	A safe lithium mimetic for bipolar disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nisha Singh Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 01/2003
8	Bipolar Disorder (Manic Depressive Psychosis) 12/2020 - 10/2012
7	COVID-19 11/2022 - 01/2021
5	Leishmaniasis 01/2014 - 01/2012
4	Infections 01/2019 - 01/2016
3	Schizophrenia (Dementia Praecox) 01/2022 - 01/2018
3	Lymphoma (Lymphomas) 01/2006 - 09/2004
2	Pain (Aches) 11/2022 - 12/2021
2	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 12/2021
2	Preterm Premature Rupture of the Membranes 02/2021 - 08/2020
2	Neuroinflammatory Diseases 01/2021 - 01/2018
2	Visceral Leishmaniasis (Kala Azar) 01/2021 - 11/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 08/2013
2	Tuberculosis (Tuberculoses) 03/2015 - 01/2013
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2006 - 09/2004
1	Fever (Fevers) 11/2022
1	Cardiotoxicity 01/2022
1	Cicatrix (Scar) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Headache (Headaches) 12/2021
1	Pruritus (Itching) 12/2021
1	Nausea 12/2021
1	Respiratory Insufficiency (Respiratory Failure) 12/2021
1	Vomiting 12/2021
1	Urinary Retention 12/2021
1	Inflammation (Inflammations) 02/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Frontotemporal Dementia (Semantic Dementia) 01/2021
1	Brain Diseases (Brain Disorder) 12/2020
1	Mania (Manias) 12/2020
1	Tremor (Tremors) 09/2020
1	Seizures (Absence Seizure) 09/2020
1	Rupture 08/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Adenoma (Adenomas) 01/2019
1	Cystic Fibrosis (Mucoviscidosis) 01/2019
1	Autism Spectrum Disorder 10/2018
1	Sepsis (Septicemia) 08/2016
1	Abscess 08/2016
1	Surgical Wound Infection 08/2016

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 07/2022 - 09/2012
7	LithiumIBA 12/2020 - 10/2012
6	Pharmaceutical PreparationsIBA 01/2021 - 10/2011
6	ebselenIBA 12/2020 - 01/2013
4	ChAdOx1 nCoV-19IBA 11/2022 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2014
3	LigandsIBA 12/2021 - 01/2003
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
2	Nucleic AcidsIBA 07/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 09/2020
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 12/2021
2	5'-Nucleotidase (5' Nucleotidase)IBA 09/2020 - 10/2012
2	Amphotericin B (Amphotericin)FDA LinkGeneric 09/2017 - 06/2012
2	miltefosine (Impavido)IBA 09/2017 - 06/2012
2	CytokinesIBA 01/2012 - 01/2005
2	CalpainIBA 07/2009 - 08/2008
2	Interleukin-1 (Interleukin 1)IBA 01/2008 - 01/2005
1	Meningococcal Vaccines (Meningococcal Vaccine)IBA 11/2022
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2022
1	Diazepam (Valium)FDA LinkGeneric 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Methylazoxymethanol AcetateIBA 01/2022
1	MineralsIBA 01/2022
1	Ketamine FDA LinkGeneric 12/2021
1	Fentanyl (Sublimaze)FDA LinkGeneric 12/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2021
1	AntigensIBA 01/2021
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2021
1	EndotoxinsIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	ParvalbuminsIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 12/2020
1	Glutamine (L-Glutamine)FDA Link 12/2020
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 12/2020
1	Antipsychotic Agents (Antipsychotics)IBA 12/2020
1	Muscarinic AgonistsIBA 09/2020
1	Pilocarpine (Ocusert)FDA LinkGeneric 09/2020
1	Receptor for Advanced Glycation End ProductsIBA 01/2020
1	Calcibiotic Root Canal SealerIBA 01/2020
1	CalciumIBA 12/2019
1	AldosteroneIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	Aminobutyrates (Aminobutyric Acid)IBA 10/2018
1	N- benzyl- N- ethyl- 2- (7,8- dihydro- 7- methyl- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 01/2018
1	Polyvinyl Chloride (PVC)IBA 08/2016

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2005
2	Drug Therapy (Chemotherapy) 01/2022 - 06/2012
2	Radiotherapy 01/2018 - 07/2009
2	Laparotomy 08/2016 - 01/2013
1	Sutures (Suture) 01/2022
1	Aftercare (After-Treatment) 01/2018
1	Oral Administration 01/2018
1	Vaginal Hysterectomy 08/2016
1	Antibiotic Prophylaxis 08/2016